Eating Disorders Trial, Recruiting (NCT05614024)

Eating Disorders Trial, Recruiting NCT05614024 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Eating Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT05614024 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eating Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are female
People aged between 18 and 45 years old
People who have been diagnosed with bulimia nervosa
People whose body weight falls within a specific healthy range (not underweight or overweight, as defined by standard medical measurements)
People who speak English

Who may not be able to join:

People who have an ongoing medical treatment, a serious medical condition, or a mental health disorder that could affect the study results or their ability to participate
People who are currently receiving therapy focused mainly on treating an eating disorder
People who are pregnant, planning to become pregnant, or breastfeeding during the study period
People who have an allergy to any ingredients in the standardised meal or shake used in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laura A Berner, Ph.D., Icahn School of Medicine at Mount Sinai

Phone: (212) 201-2679

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05614024

Sponsor: Icahn School of Medicine at Mount Sinai

Phase: Not Applicable

Status: Recruiting

Condition: Eating Disorders

Trial contact: (212) 201-2679

More information: https://clinicaltrials.gov/study/NCT05614024

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are female
People aged between 18 and 45 years old
People who have been diagnosed with bulimia nervosa
People whose body weight falls within a specific healthy range (not underweight or overweight, as defined by standard medical measurements)
People who speak English

Who may not be able to join:

People who have an ongoing medical treatment, a serious medical condition, or a mental health disorder that could affect the study results or their ability to participate
People who are currently receiving therapy focused mainly on treating an eating disorder
People who are pregnant, planning to become pregnant, or breastfeeding during the study period
People who have an allergy to any ingredients in the standardised meal or shake used in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Icahn School of Medicine at Mount Sinai

Registry

ClinicalTrials.gov

Start date

13 May 2024

Est. completion

1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Functional near-infrared spectroscopy (fNIRS)-measured neural activation and connectivity; Go/no-go task performance; Number of loss-of-control eating and purging episodes; Severity of loss-of-control eating scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov